[Studies on percutaneous absorption of flumetasone pivalate and salicylic acid from a corticoid combination for topical use (author's transl)].
The combination of 0.02% flumetasone pivalate and 1% salicylic acid in a water-alcohol solution (Locasalen) is a novel therapeutic for topical treatment of the hairy scalp and also for the cosmetically acceptable treatment of other skin areas, that is, exposed skin. An investigation was carried out in 6 patients with psoriasis capitis and 6 control subjects in order to determine whether the use of Locasalen Tincture on the hairy scalp leads to percutaneous absorption of the corticosteroid and the salicylic acid. In the patients with psoriasis a few slight transient changes in biochemical-endocrinological parameters were observed, but not in the control subjects. However, these changes remained within the normal, non-pathological range so that they are of no clinical consequence. Percutaneous absorption of salicylic acid was not observed in either patient group.
D000287:Administration, Topical; D004338:Drug Combinations; D005443:Flumethasone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D011565:Psoriasis / Q000378:metabolism; D012459:Salicylates / Q000008:administration & dosage / Q000378:metabolism*; D012869:Skin Absorption; D012996:Solutions
D004338:Drug Combinations; D012459:Salicylates; D012996:Solutions; D005443:Flumethasone; D006854:Hydrocortisone
Untersuchungen über die perkutane Resorption von Flumetasonpivalat und Salicylsäure aus einem Kortikoid-Kombinationsexternum.